{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/124-US9,335,321(active).pdf"}, "page_content": "Goldsmith, P (2004). Zebrafish as a Pharmacological Tool: The how, Why and when. Curr, Opin. Pharmacol. 4, 504- 512.\n\nHallare, A., Nagel, K., Kohler, H. R. and Triebskorn, (2006). Comparative Embryotoxicity and Proteotoxicity of Three Carrier Solvents to Zebrafish (Danio Rerio) Embryos. Ecotoxicol. Environ. Saf 63, 378-388.\n\n(b) determining the parameters of the angiogenic modulat- ing activity of said test agent at the level of NOAEC.\n\n2. The method of claim 1, wherein in the first tier, the teleost embryos at 4 to 20 hours post fertilization are bathed in\n\nmicity.\n\nTotally, 1431 single compounds, 107 herbs singularly and\n\nsupplier\n\nresponses.\n\nc. Tier 3 Toxicity testing at the NOAEC was carried out. All 11\n\ntests.\n\na\n\nthe Exp.\n\nR.\n\n25\n\n30\n\n40\n\n45\n\n50\n\n55\n\n60\n\nHasan, R.\n\nS.\n\nJ.\n\nBicknel,\n\nR., for Exp.\n\nthe\n\n1. A biological method of screening an agent having angio- genic modulating activity, which is carried out by a hierar-\n\n(a)\n\n(b)\n\nany\n\nves-\n\nof the\n\ntest\n\nan\n\nto\n\nthe\n\n(b)\n\nthere\n\nthe\n\nno\n\ntest\n\nagent\n\n(a)\n\nof and\n\nan\n\nUS 9,335,321 B2\n\n11\n\n12\n\nembryo medium containing different concentrations of the\n\n10. The method of claim 1, wherein step (ii) comprises\n\ndetermining the adverse effects of the agents on teleosts at\n\ntest agent for a determined period of time; in the second tier,\n\ndifferent concentrations after at least a 24 hour exposure time.\n\nthe adverse effects of the test agent on the teleost embryos,\n\n11. The method of claim 10, wherein the adverse effects\n\nsuch as death or malformation, are determined at different\n\ninclude death and malformations.\n\nconcentrations after at least a 24 hour exposure time; and in\n\n12. The method of claim 11, wherein the malformations are\n\nthe third tier, alteration of intersegmental vessels is used as an\n\nobserved as changes on the external morphology of teleost.\n\nindicator for angiogenic modulating activity.\n\n13. The method of claim 10, wherein the no observed\n\n3. The method of claim 1, wherein, in the first tier, the", "type": "Document"}}